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An enduring challenge in the vaccinology of infectious pancreatic necrosis virus (IPNV) is the lack of correlation
between neutralizing antibodies and protection against mortality. To better understand the immunological basis of
vaccine protection, an efficacy trial including Atlantic salmon (Salmo salar L.) vaccinated with a high antigen (HiAg)
or low antigen (LoAg) dose vaccine was carried out in a cohabitation challenge model using the highly virulent
Norwegian Sp strain NVI015. To pinpoint the immunological basis of vaccine protection, pathogenic mechanisms of
IPNV were unraveled in control fish while obtaining feedback on mechanisms of protection in the vaccinated fish.
During the incubation period, infection rates were highest in control fish, followed by the LoAg group with the
lowest infections being in the HiAg group. Although both the liver and pancreas are target organs prone to tissue
damage, infection in the liver was delayed until acute infection in most fish. A correlate of pathology determined as
the cutoff threshold of viral copy numbers linked to tissue damage in target organs was estimated at ≥ 107.0, which
corresponded with an increase in mortality. The kinetics of IFNα and Mx expression suggests that these genes can
be used as biomarkers of IPNV infection progression. Mechanisms of vaccine protection involved reducing infection
rates, preventing infection of the liver and reducing virus replication in target organs to levels below the correlate
of pathology. Overall, the study shows that antigen dose corresponds with vaccine efficacy and that antibody levels
can be used as a signature of protective immunity against pathological disease and mortality.Introduction
Infectious pancreatic necrosis virus (IPNV) is a highly
contagious disease causing high mortality in juvenile sal-
monids. The disease was first reported as catarrhal en-
teritis mainly affecting fingerlings in North America in
the 1940s [1] although the virus was first isolated and
characterized in 1960 [2]. It is a double stranded RNA
virus and a prototype member of the Aquabirnavirus in
the Birnaviridae family [3]. The expansion of aquacul-
ture which has led to intensive fish farming has resulted
in an increase in outbreaks not only in fingerlings but
also in postmolts [4]. To reduce the occurrence of* Correspondence: oystein.evensen@nvh.no
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distribution, and reproduction in any mediumoutbreaks, research in the last two decades has focused
on finding the most protective, ecosafe and cost effective
vaccines able to reduce mortality and post challenge per-
sistent infections [5-8]. Although several strategies have
been explored to develop efficacious vaccines, success
has been limited by the general failure of most vaccines
to produce long lasting immunity that reduces mortality
and eliminates post challenge persistent infections.
Factors leading to vaccine failure have been reviewed
by different scientists. In 1986, Olesen and Jogensen [9]
reported that antibody responses in salmonids were in-
herently variable and that they could not be correlated
with protection. A subsequent study carried out by
Bootland et al. [10] in 1990 showed that inactivated vac-
cines were able to reduce mortality but did not prevent
infection. This is in line with several other studies thatentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lating antibodies. In a more recent study, we delivered
IPNV VP2 as a fusion protein in Escherichia coli-based
subunit vaccines, plasmid DNA encoding segment A,
PLGA nanoparticles and inactivated whole viral vaccines
(IWV) in water-in-oil formulation in Atlantic salmon
[11]. Overall, IWV were superior but a protective pro-
portion of 56% for the most protective vaccine was con-
sidered low and this was coupled with the general failure
to eliminate post challenge persistent infections. These
findings still confirm observations from previous reports
showing that vaccination can reduce mortality but fail
to eliminate infection in survivors. Although different
scientists [12-20] have reviewed the efficacy of different
IPNV vaccines, less attention has been directed at eluci-
dating the functional mechanisms of vaccine protection
in fish. What is eminent from these studies is that they
lack detail on mechanisms of vaccine protection because
they do not pinpoint the exact mode of action by which
IPNV vaccines protect fish from dying. In the absence of
such detail it is difficult to fully account for factors that
lead to vaccine failure.
Unlike in IPNV vaccinology, vaccine development in
higher vertebrates has taken a more functional approach.
In mammalia, vaccines are licensed based on a good
understanding of mechanisms of protection and defined
correlates of protection [21]. Although several vaccines
have been licensed, there is no established correlate of
protection for IPNV vaccines. Apart from determining
the relative percent survival (RPS) as a measure of effi-
cacy, the exact mode of protection induced by these vac-
cines has not been determined. It is not clear whether
vaccination prevents virus penetration at portals of
entry, dissemination, seeding in target organs or tissue
damage in target organs. Besides, there is no established
standard antibody titer that corresponds with protection.
In view of these gaps, a vaccine efficacy trial was designed
using fish vaccinated with a high antigen (HiAg) and a low
antigen (LoAg) dose vaccine, put to cohabit with unvac-
cinated control fish. The study sought to unravel the
pathogenic mechanisms of IPNV in control fish while get-
ting feedback on mechanisms of protection in vaccinated
fish. Hence, the study was aimed at (i) documenting
whether antibody responses at the time of challenge cor-
respond with protection against mortality, (ii) determining
tissue tropism, the pathogenic sequence of infection and
to what extent vaccines interfere with pathogenesis, and




A highly virulent recombinant IPNV strain produced by
reverse genetics using cDNA from the Norwegian Spstrain rNVI015 (Genbank: AY379740) [22] was used as
antigen for the production of the vaccine and in all immu-
noassays carried out during the study. The virus was also
used to challenge the fish. Propagation of the virus was
done in Rainbow trout gonad (RTG-2) cells maintained in
Leibowitz L-15 media (GibcoW Life Technologies, Palsey,
UK) supplemented with 10% fetal bovine serum (FBS),
10% L-glutamine and gentamycin 50 μg mL-1.
Vaccine formulations
Vaccine antigens were made by growing the highly viru-
lent Norwegian strain rNVI015TA once in RTG-2 cells
followed by another passage in Asian Group-strain K
cells (AGK) [23]. Viruses were harvested when a total
cytopathic effect (CPE) was observed from both cell
lines. The AGK cell line gave yields of approximately
2 × 1010 TCID50/mL. Thereafter, two vaccines were con-
stituted as a high antigen dose (HiAg) with 2 × 1010
TCID50/mL and a low antigen dose (LoAg) with 2 × 10
9
TCID50/mL and were administered at 0.1 mL/fish. The
vaccines were prepared as oil-based inactivated (water-
in-oil) formulations. Emulsification of the viral antigen
with adjuvant was done using a homogenizer with a
standard emulsification stator/rotor connected to an
emulsion screen. The oil-based antigen preparation was
formulated as water-in-oil (w/o), where the water phase
(containing viral antigens) was dispersed into an oil
phase (continuous phase containing emulsifiers and sta-
bilizers). Vaccine preparation and quality assurance were
all carried out by PHARMAQ AS, Oslo.
Experimental fish and study design
Fish experiments were carried out at the Aquaculture
Research Station at the University of Tromsø, Norway,
using susceptible Atlantic salmon (Salmo salar L). At-
lantic salmon parr with an average weight of 30 grams
were used in the study. Fish were assigned into three
parallel tanks and were fed commercial dry pellets
(Skretting AS, Stavanger, Norway) ad libitum using
automated equipment while water in the tanks was pre-
treated with UV-light. Each vaccine group was allocated
a total of 114 fish that were split into 38 fish per tank
(Figure 1). For identification, fish were intraperitoneally
implanted with pit-tag-numbers using a tag applicator.
Tag numbers were entered in an excel sheet (Microsoft
Excel™) using an automated electronic reader (ARE-H5-
150, Trovan Ltd, Koln, Germany) remotely connected to
a computer. Vaccination was carried out by intraperito-
neally injecting each fish with 0.1 mL of the vaccine.
The control group was allocated a total of 90 fish of
which 30 were put in each of the three parallel tanks
(Figure 1). Control fish were injected with 0.1 mL/fish of
phosphate buffered saline (PBS). During tagging, vacci-
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Figure 1 Study design showing a challenge model based on a three parallel tank system. Each of the vaccine groups was allocated 38 fish
while the unvaccinated control group had 30 fish in each tank. At day 56 (8 weeks) post vaccination, fish were challenged with a highly virulent
Norwegian IPNV strain NVI-015TA (AY379740) using a cohabitation model. In each tank, 13 fish injected with 1 × 107 TCID50/mL of the challenge
virus were added to serve as virus shedders.
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Pharmaceuticals, Alesund, Norway). After vaccination,
fish were subjected to a light regime to induce smoltifi-
cation during the immune induction period. After eight
weeks post-vaccination, fish were challenged in a co-
habitation model by adding 13 virus shedders in each
tank (Figure 1). The virus shedders were intraperitone-
ally injected with 0.1 mL of the homologous virus
(rNVI015TA) to the one used in vaccine preparation at a
concentration of 1 × 107 TCID50/mL.Sampling
Pre-challenge sampling was carried out on days 28 and
56 post vaccination. At 4, 7, 10, 14, 21 and 56 days post
challenge (dpc) more samples were collected as shown
in the study design in Figure 1. The samples collected
included head-kidney, spleen, gills, heart, muscle, liver
and pancreas in RNA-later and 10% formalin. Head kid-
ney samples were also collected in transport medium
consisting of L-15 maintenance media (section “Viruses
and cells”) without FBS but with 30% glycerol while
blood samples were collected in EDTA tubes and stored
at −20°C.Post challenge virus re-isolation
Head-kidney samples collected in transport media were
homogenized and 100 μL was inoculated onto confluent
RTG-2 cells at a dilution of 1:10 and 1:100. The inocu-
lated cells were incubated at 15°C for seven days. There-
after, the supernatant was passaged onto new confluent
RTG-2 cells and observed for another seven days. The
presence or absence of virus was scored on the basis of
cytopathic effects (CPE). Similarly, 100 μL of whole
blood stored in EDTA vacutainer tubes was inoculated
on confluent RTG-2 cells. The same procedure of
screening as described above was followed.
ELISA
Briefly, 100 μL per well of polyclonal rabbit anti-IPNV
(K95) [24] was coated onto 96 well micro-titer plates
(Nunc Maxisorb, Roskilde, Denmark). Thereafter, the
plates were placed at 4°C overnight. After washing, 250
μL of 5% dry milk in PBS/T was added to each well fol-
lowed by incubation at room temperature for 2 h. After
washing, 100 μL IPNV supernatant was added to each
well and the plates were incubated for 2 h. Test sera
diluted in a twofold dilution starting at 1:50 together
with plasma controls, blank (1% dry milk PBS/T) and
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the plate after washing. Thereafter, plates were incubated
at 4°C overnight. After washing, an anti-salmon mouse
monoclonal antibody (4C10) [25] was added to each well
followed by incubation for 1 h. A goat-anti-mouse anti-
body conjugated to a horseradish peroxidase (DAKO;
Glostrup, Denmark) was added to each well after wash-
ing. This was followed by adding 0.1 mL OPD substrate
(O-Phenylenediamine dihydrochloride, DAKO; Glostrup,
Denmark) containing 30% H2O2 to each well. Color de-
velopment was stopped by adding 0.05 mL H2SO4 per
well. The results were read using an ELISA reader spec-
trophotometer (TECAN, Genios, Boston, USA) at a
wavelength of 492 nm.Histology and immunohistochemistry (IHC) staining
The technique described by Evensen and Lorenzen [26]
was used for immunohistochemistry (IHC) staining.
Briefly, after deparaffinization and hydration, tissue sec-
tions were blocked with 5% bovine serum albumin
(BSA) in 1M Tris-buffer pH 7.6 for 20 min. After wash-
ing, anti-IPNV polyclonal rabbit antisera (K95) diluted
in 2.5% BSA was added to each slide. After incubation
for 30 min a secondary biotinylated anti-rabbit antibody
(Dako, Glostrup, Denmark) was added after washing.
This was followed by adding streptavidin alkaline phos-
phatase (Sigma, Aldrich, St Louis, USA) diluted in 2.5%
BSA in tris-buffer after incubation for 30 min. After
washing, fast red substrate (Sigma, Aldrich) was added
to each slide and observed for 15 min. The reaction was
stopped by washing the slides in tap water followed by
counterstaining using hematoxylin dye for 2 min. There-
after, slides were observed under a light microscope. The
histology was carried out as described elsewhere [27].RNA extraction and cDNA synthesis
Total RNA from head-kidney, pancreas, liver and spleen
organs was extracted using a combination of the TrizolW
(GibcoW Life Technologies, Palsey, UK) and RNAeasy
Mini kit (Qiagen, Hilden, Germany) methods. Briefly, 30
mg of tissue was homogenized in trizol and spun at 12
000 × g for 10 min at 4°C. Thereafter, 0.2 mL of chloro-
form was added to each vial followed by vortexing for
15 s. The samples were incubated at room temperature
for 5 min followed by spinning at 12 000 × g for 15 min.
The upper aqueous phase was transferred to new vials
and mixed with 0.6 mL 70% ethanol by vortexing. Sam-
ple solutions were transferred to RNeasy spin columns
placed in 2 mL collection tubes. Thereafter, the Qiagen
protocol was used according to the manufacturer’s
recommendations. The quality of purified RNA was
assessed by running the samples on 1% agarose gel and
the samples were quantified using a spectrophotometer(NanoDropW ND-1000, Thermo Scientific Inc, Wilming-
ton, USA).
The synthesis of cDNA was carried out in 20 μL reac-
tion volumes using the quantiTectW reverse transcrip-
tion method (QuantiTectW, Qiagen, Hilden, Germany).
Briefly, 2 μg gDNA wipeout buffer (7×) and 1 μL of
RNAse-free water were added to 1 μL of template RNA.
After incubation at 42°C for 2 min, 1 μL of quantiscript
reverse transcriptase, 4 μL quantiscript RT buffer (5×)
and 1 μL RT primer mix were added to the template so-
lution on ice. The incubation steps were carried out in a
thermocycler (Bio-RAD, DNA Engine, Peltier Thermal
Cycler, Hercules, California, USA) at 42°C for 15 min
followed by a second step at 95°C for 3 min. The cDNA
was diluted 1:5 using RNAse free water and was stored
at −80°C until use. Two microliters were used for
each reaction in the Syber green qPCR assay (Roche,
Mannheim, Germany).
Construction of the standard curve
A plasmid (pUC19) construct containing segment B of
the SP strain NVI015 [28] was used as template for ge-
nerating the standard curve used for quantifying virus in
infected tissues. Transformation of plasmid DNA was
carried out in Escherichia coli competent cells (Qiagen
Hilden, Germany). Thereafter, linearized plasmid DNA
was quantified using a spectrophotometer (NanoDropW
ND-1000, Thermo Scientific Inc.). Plasmid DNA was
serially diluted from 109 to 101 and diluents were used
to estimate the number of viral copies using the
master hydrolysis probe method (Applied Biosystem,
Warrington, UK). All reactions for quantitative PCR
(qPCR) were constituted as 20 μL volumes consisting of
2.0 μL diluted plasmid DNA template, 2.0 μL primers,
1.3 μL Activator (50 mM), 7.4 μL LightcyclerW 480 RNA
master hydrolysis probe (2.7×), 1.0 μL enhancer (20x)
and 6.3 μL dH2O (PCR-grade). qPCR was done using
the LightCyclerW 480 thermocycler (Roche Diagnos-
tics, Mannheim, Germany) in 96 multiwell plates
(Roche Diagnostics). Copy numbers were calculated as
described by Godornes et al. [29] while the standard
curve was generated by plotting the Ct values on the
Y axis and the log of copy numbers on the X-axis.
Quantification of virus
RNA from headkidneys, spleen, liver and pancreas were
used as template for the quantification of virus. The
same primers and probe used for the standard curve
were also utilized to quantify virus in these organs. A
one-step kit (Roche Diagnostics) was used for this pur-
pose in the LightCyclerW 480 thermocycler with the fol-
lowing conditions: 63°C for reverse transcription, 95°C
for 30 s to stop the RT reaction and initial denaturation;
95°C for 10 s, 60°C for 30 s and 72°C for 1 s for qRT-
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ples was estimated by relating the Ct values obtained
in the samples to the standard curve generated using
plasmid DNA according to the method described by
Yu et al. [30].
Real time PCR for innate genes
Real time PCR using the SYBRW green (Roche) detection
method was used to determine the expression of IFN-α
and Mx genes in different organs. Primers for these
genes as well as the house-keeping genes β-actin and
ELF-α are presented in Table 1. RT-PCR amplification
cycles were carried out in a Light-CyclerW 480 machine
(Roche Applied Science). qPCR reactions were consti-
tuted and performed as described above with the
following cycling conditions: 95°C for 10 min initial de-
naturation; 95°C for 3 s, annealing temperatures for 10 s,
72°C for 30 s (40 cycles). The melting curve analysis was
done at 95°C for 5 s and 65°C for 1 min. Transcription
levels for the target genes were quantified relative to in-
ternal control genes using the delta-delta method
[31,32].
Statistical analysis
Survival analysis was used to generate survival plots and
to determine the proportion hazard risk ratios for the
different vaccinated groups using p/c mortality data.
Analysis of Variance (ANOVA) was used to determine
the difference in antibody response between the different
vaccine groups when compared to the unvaccinated con-
trol. The Pearson Chi-square test was used to determine
the correlation between mortality and the presence of
disease.
Results
Post challenge survival proportions (PCSP)
Clinical signs of irregular swimming and distention of
the abdomen were observed in affected fish. DailyTable 1 Primers used for quantitative PCR
Gene GenBank Seq
β-actin BT047241.2 F CCA
R GG
ELF-α AF321836 F GCT
R ACT
Mx (1) SSU66475 F TGC
R GG




R CCGmortality data of fish collected from each tank was used
to generate the PCSP and the Kaplan Meyer’s survival
plots. Among the virus shedders, mortality started on
day six p/c. The cohabiting fish started dying 19 dpc in
the control groups while in the LoAg group they started
dying 21 dpc and in the HiAg group mortality was
delayed until 32 dpc (Figure 2). There was a significant
difference in mortalities between vaccinated fish and
controls (p < 0.0001 for both HiAg and LoAg). The risk
of fish dying in the LoAg group relative to the most pro-
tected group (HiAg) was 9.38 while the risk of unvaccin-
ated fish in the control group relative to the HiAg group
was 21.05 (Table 2). Onset of mortality was dependent
on antigen dose; mortality in the HiAg started 11 days
after the LoAg group while fish in the control group
started dying two days earlier than in the LoAg group.
Overall, vaccine efficacy corresponded to antigen dose,
as shown by the high dose of 2 × 1010 TCID50/mL used
in the HiAg, which was protected by PCSP > 90% com-
pared to the low dose of 2 × 109 TCID50/mL used in
LoAg that had low protection (42.1%). Amongst the
controls, 15.4% of the fish survived.
Antibody responses
Antibody levels in the HiAg were >3-fold higher than
levels in the LoAg at challenge (Figure 3). Furthermore,
antibodies in the HiAg group showed a gradual decline
post challenge with the lowest levels being on 21 dpc
(Figure 3). Thereafter, antibody levels in the HiAg group
were maintained at the same level given that there was
no significant difference (p > 0.3340) between levels
detected at 21 dpc (mean OD490 = 4.864 ± SEM = 0.1029,
n = 12) and 56 dpc (mean OD490 = 0.6432 ± SEM =
0.1210, n = 12) (Figure 3). In the LoAg group, levels
decreased during the incubation period leading to deple-
tion of antibodies by 21 dpc at the onset of mortality. By
56 dpc, antibody levels had not increased above those
































Figure 2 Kaplan Meyer’s post challenge survival proportion (PCSP) plots for the vaccinated and unvaccinated-control groups. The
highest PCSP was in the HiAg group followed by the LoAg group and was the lowest in the unvaccinated control group.
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increasing antibody levels between 10 dpc and 56 dpc
(Figure 3). High antibody levels maintained during acute
infection in the HiAg group (Figure 3) corresponded
with delayed onset and low mortalities in this group
(Figure 2). On the contrary, the LoAg group which was
depleted of antibodies during the acute infection period
had an early onset and high mortalities. In summary,
these data show that antigen dose corresponded with
post immunization antibody levels and PCSP. In
addition, high antibody levels (≥ 1.40 OD490, Figure 3)
prior to challenge could have played an important role
in generating the high protection levels obtained in the
HiAg group (PCSP ≥ 90%, Figure 2).
Histopathology and immunohistochemistry (IHC)
During acute infection, viral antigens were only detected
in the pancreas, liver, spleen and headkidney tissues of
the LoAg and control groups by IHC (Tables 3 and 4)
and not in the HiAg group. In the pancreas, gross patho-
logical changes were characterized macroscopically by
hemorrhages (Figure 4a). Single acinar cells whose cyto-
plasm was filled with virus were observed showing dif-
ferent stages of cellular degradation and later apoptosisTable 2 Proportion of hazard risk ratios for fish
vaccinated with the LoAg vaccine and unvaccinated
control fish challenged with Sp strain NV015
Vaccine group Hazard risk Std err P > |z| 95% Conf. Interval
LoAg 9.384 3.190 0.000 4.820 – 18.271
Cntrl 21.056 7.147 0.000 10.826 -40.952
Hazard risk ratios are expressed relative.(Figure 4b). As the infection progressed, there was total
destruction of the pancreatic acinar cells. Similarly,
infected hepatocyte cytoplasm was repleted with IPNV
(Figure 4c and d), and virus infected cells and neighbor-
ing cells formed apoptotic bodies. In kidney tissues, virus
infected cells were confined to interstitial tissues and
intravascular leukocytes (Figure 4e). In the spleen, detec-
tion of viral antigens was evenly distributed in the white
and red pulp (Figure 4f ). There was no virus detected inFigure 3 Antibody levels detected by ELISA. Four weeks post
vaccination (wpv) up to 8 wpc, which is equivalent to day of
challenge, shows antibody responses generated during the immune
induction period. Days after 8 wpc show antibody levels after
challenge. There is a marked decline in circulating antibody levels
post challenge in the HiAg and LoAg group. The control group has
raised levels of antibodies by 21 dpc as a consequence of the
challenge virus.
Table 3 Number of fish detected with virus by IHC and qPCR at 21 days post challenge
Vaccine
group






No. of infected fish % No. of infected fish %
Control Headkidney 3/6 50.0% 6/10 60.0% 7.51, 7.66, 7.22
Pancreas 3/6 50.0% 10/10 100.0% 8.11,8.52, 7.71
Liver 3/6 50.0% 10/10 100.0% 7.35, 8.72, 7.29
Spleen 3/6 50.0% 5/10 50.0% 6.54
Gills 2/6 33.3% ND - -
Muscle 3/6 50.0% ND - -
Heart 0/6 00.0% ND - -
Pyloric ceca 0/6 00.0% ND - -
LoAg Headkidney 3/6 50.0% 10/10 100.0% 7.64, 7.88, 7.52
Pancreas 3/6 50.0% 10/10 100.0% 8.99, 9.07, 8.99
Liver 3/6 50.0% 10/10 100.0% 8.35, 9.02, 9.03
Spleen 3/6 50.0% 10/10 100.0% 8.21, 8.05, 8.65
Gills 0/6 00.0% ND - -
Muscle 2/6 33.3% ND - -
Heart 0/6 00.0% ND - -
Pyloric ceca 0/6 00.0% ND - -
HiAg Headkidney 0/6 00.0% 10/10 100.0% -
Pancreas 0/6 00.0% 10/10 100.0% -
Liver 0/6 00.0% 4/10 40.0% -
Spleen 0/6 00.0% 10/10 100.0% -
Gills 0/6 00.0% ND - -
Muscle 0/6 00.0% ND - -
Heart 0/6 00.0% ND - -
Pyloric ceca 0/6 00.0% ND - -
ND = not done *Tissue detected with pathological changes are shown in italics.
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(not shown). As shown in Tables 3 and 4, viral antigens
were only detected by IHC in tissues that had copy
numbers ≥ 106.5 and as such, no viral antigens were
detected by IHC in tissues of the HiAg group that had
viral loads with a mean of viral copy numbers ≤ 102.6
during the acute stage of infection.
Infection rates as determined by qPCR
The four most infected organs as assessed by IHC
(Tables 3 and 4) were used to determine infection rates
(morbidity) and to compare differences in tissue suscep-
tibility by qPCR. During the incubation period (7 dpc),
the overall infection rate in the control group showed
high infection rates reaching up to 100% (Figure 5a).
The LoAg group (Figure 5b) had higher infection rates
than the HiAg group (Figure 5c). Generally, there was a
gradient of infection rates with the highest being in thecontrol group, followed by the LoAg group while fish in
the HiAg were less infected during the incubation period
(Figure 5a-c). Comparison of tissue susceptibility showed
that the pancreas, spleen and headkidney had higher
infection rates than the liver in all groups with the high-
est infections found in the controls (30%, 7 dpc)
(Figure 5a-c), followed by the LoAg (10%, 7 and 14 dpc).
During the acute stage (21 dpc), the overall infection
rates increased in all groups reaching 100% (n = 10)
(Figure 5a-c). Comparison of tissue susceptibility showed
that infection rates in the liver of the control fish had
reached 100% by 21 dpc which corresponded with early
onset of mortality in this group (19 dpc, Figure 2). Al-
though infection rates increased to 100% in the spleen,
pancreas, and headkidney in the HiAg group, the liver
was less infected (≤ 40%, Figure 5c). Hence, the liver was
the organ with the lowest infection rates in the HiAg
group during acute infection.
Table 4 Number of fish detected with virus by IHC and qPCR at 56 days post challenge
Vaccine
group






No. of infected fish % No. of infected fish %
Control Headkidney 3/6 50.0% 10/10 100.0% 6.78, 6.52, 6.55
Pancreas 3/6 50.0% 10/10 100.0% 6.78, 6.54, 7.12
Liver 3/6 50.0% 10/10 100.0% 6.57, 6.52, 6.72
Spleen 3/6 50.0% 10/10 100.0% 6.93, 6.85, 6.51
Gills 2/6 33.3% ND - -
Muscle 2/6 33.3% ND - -
Heart 0/6 00.0% ND - -
Pyloric ceca 0/6 00.0% ND - -
LoAg Headkidney 3/6 50.0% 10/10 100.0% 6.78, 6.62, 6.55
Pancreas 3/6 50.0% 10/10 100.0% 7.18, 6.54, 7.12†
Liver 3/6 50.0% 8/10 80.0% 6.57, 7.22†, 6.72
Spleen 3/6 50.0% 10/10 100.0% 6.93, 6.85, 6.51
Gills 0/6 00.0% ND - -
Muscle 2/6 33.3% ND - -
Heart 0/6 00.0% ND - -
Pyloric ceca 0/6 00.0% ND - -
HiAg Headkidney 0/6 00.0% 10/10 100.0% -
Pancreas 0/6 00.0% 9/10 90.0% -
Liver 0/6 00.0% 6/10 60.0% -
Spleen 0/6 00.0% 10/10 100.0% -
Gills 0/6 00.0% ND - -
Muscle 0/6 00.0% ND - -
Heart 0/6 00.0% ND - -
Pyloric ceca 0/6 00.0% ND - -
ND = not done *Tissue detected with pathological changes are shown in italics.
†Lowest log of viral copy numbers at which pathology was detected in the infected organs.
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tropism for the headkidney, spleen and pancreas during
the incubation period. Infection rates increased in these
organs during the acute stage. Liver infection and path-
ology during acute infection in the less protected groups
coincided with the onset of mortality. The HiAg group
did not show any liver infection in 60% of the fish exam-
ined during the acute stage (21 dpc; Figure 5c).
Quantification of virus by qPCR and correlate of
pathology
Viral copy numbers detected by qPCR for the four most
susceptible tissues detected by IHC (Tables 3 and 4) are
shown in Figure 6a-c. During the incubation period (7
dpc), there was no significant difference in viral copy num-
bers between the vaccinated and control fish (Figure 6a-c).
The upper limit of the mean viral copy numbers for allgroups was estimated at 102.6 (Figure 6a-c). The liver had
lower viral copy numbers than the other organs during
the incubation period. During acute infection (21 dpc), the
LoAg and control groups had higher viral copy numbers
in all organs than the levels detected during the incubation
period (Figure 6a-c). In contrast, the mean viral copy
numbers in infected organs of the HiAg group were low
and did not increase above levels detected during the in-
cubation period (Figure 6c). For example, there was no
significant difference between the mean viral copy num-
bers detected in the headkidney (p = 0.9398) at 7 dpc
(mean OD490 1.710 ± SEM 0.2624) compared to 21 dpc
(mean OD490 1.727 ± SEM 0.09661) and for the liver
(p = 0.3362) at 7 dpc (mean OD490 1.485 ± SEM 0.1950)
compared to 21 dpc (mean OD490 1.245 ± SEM 0.1374)
suggesting that levels of viral copy numbers detected in
the HiAg group during the incubation period and acute
Figure 4 Pathological changes during the acute stage of infection. a) Gross picture showing hemorrhages (arrow) in the area of the
exocrine pancreas of Atlantic salmon smolt. b) Destruction and necrosis of pancreatic acinar cells due to IPNV infection (arrow) with pyknotic
nuclei (*). c) Different stages of cellular degradation and apoptosis (long horizonal arrow) in the liver (vertical arrow). d) Extensive distribution of
virus in the liver (red coloration). e) Virus in interstitial spaces and leukocytes of the excretory kidney. Melanomacrophages (M) appear as dark
spots. f) Virus in the white (W) and red (R) pulps of the spleen.
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http://www.veterinaryresearch.org/content/44/1/7stage of infection were the same. Similarly, there was no
significant difference between the mean viral copy num-
bers detected in the pancreas (p = 0.1024) at 10 dpc (mean
OD490 1.523 ± SEM 0.1980) compared to 21 dpc (mean
OD490 2.040 ± SEM 0.1453) and for the spleen
(p = 0.3794) at 10 dpc (mean OD490 1.523 ± SEM 0.1980)
compared to 21 dpc (mean OD490 1.805 ± SEM 0.1354),
further confirming our observation that viral copy num-
bers in the HiAg group did not increase during the acute
stage of infection but remained at the same levels as those
detected during the incubation period. Put together, data
in Figures 3 and 6 suggest that high antibody levels main-
tained after challenge in the HiAg group could have played
a role in the maintenance of viral copy numbers at the
same low level as detected during the incubation period.
On contrast, depletion of antibodies during acute infection
in the LoAg group corresponded to an increase in viral
copy numbers to levels above those detected during the
incubation period.
To examine for a possible correlation between virus
replication levels and pathology, we determined the
quantity of viral copy numbers in organs that had tissue
damage as observed by histology and IHC. The lowestviral copy numbers at which tissue damage was observed
in the liver and pancreas was equivalent to 107.22 and
107.12, respectively (Tables 3 and 4). All fish with viral
copy numbers above these cutoff points had tissue dam-
age. These data suggest that viral copy number ≥ 107.0
correlated with tissue damage in target organs and
that this endpoint could serve as a correlate of path-
ology. It is worth noting that low antibody levels
detected in the LoAg and control groups corre-
sponded with viral copy number ≥ 107.0 which in turn
correlated with tissue damage in the target organs. In
contrast, high antibody levels in the HiAg group cor-
responded with low viral loads that corresponded
with the absence of tissue damage in the target
organs. Another important difference between the
HiAg group compared to the LoAg and control
groups is that liver pathology corresponded with high
mortality in the LoAg and control groups. These
findings suggest there is a correlation between pro-
tective immunity and protection against development
of pathology in target organs. Furthermore, 1.4 OD490
antibody levels corresponded to the absence of tissue
damage in the HiAg group (Figure 3).
Figure 5 Number of fish infected with IPNV in different organs detected by qPCR. Number of infected fish in controls (a), LoAg (b) and
HiAg (c) groups at different days post challenge (dpc) up to 56 dpc. N = 10 for all groups at all time-points.
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Given that IHC and RT- PCR are indirect methods of
measuring virus presence , we included examination of
live virus using standard cell culture and show that the
control groups had infective virus from headkidney sam-
ples during the incubation period (already from 4 dpc,
Table 5). The presence of antibodies in the vaccinated
groups (HiAg and LoAg) corresponded to the absence of
virus from headkidney and blood samples during the
incubation period. During the acute stage (21 dpc),infection rates were higher in the LoAg and control
groups than in the HiAg group (Table 5).
Expression of IFNα and Mx
Expression levels of IFN-α and Mx during the incuba-
tion and acute stages of infection are shown in
Figure 7a-d. During the incubation period, the control
group showed expression of IFN-α (Figure 7a) and Mx
(Figure 7c) in all virus infected tissues while expression
of these genes was low in both vaccinated groups. The
Figure 6 Relative quantification of virus using qPCR in the infected organs. Bars show the mean of the log of viral copy numbers in
headkidney, pancreas, liver and spleen of the controls (a), in LoAg (b) and HiAg (c) groups at different times post challenge. The control group
shows a high level of virus already by 7 dpc increasing up to 56 dpc while the LoAg group shows a marked increase by 21 dpc. The HiAg fish
have low viral load throughout the observation period (n = 12 ± SEM). Labeling is the same in all figures.
Table 5 Virus re-isolation on RTG-2 cells from headkidney and blood samples
Sample Vaccine Number of fish detected with virus per timepoint (12 fish were examined at each timepoint)
0 4 7 10 14 21 56
Headkidney HiAg 0 0 0 0 0 1 7
LoAg 0 0 0 0 0 9 11
Control 0 12 5 9 5 10 11
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Figure 7 Expression of IFN-α and Mx detected by real time PCR from different organs. (a) IFN-α 7 dpc (b) FN-α 21 dpc (c) Mx 7 dpc and
(d) Mx 21 dpc in the headkidney, spleen, liver and pancreas of controls, LoAg and HiAg groups. IFN-α and Mx expression correlates with viral
infection and is the highest in the controls at 7 dpc. By 21 dpc, the LoAg group shows the highest expression of both genes in all organs.
N = 10–12, ± SEM.
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(Figure 7a) while Mx was the highest in the pancreas
(Figure 7c). The liver with lower infection rate had poor
correlates of viral infection with IFN-α and Mx during
the incubation period, r2 = 0.27 and r2 = −0.18, respect-
ively (Table 6).
During the acute stage (21 dpc) there was a systematic
trend that showed that viral loads correlated with IFN-α
(r2 ranging from 0.42 to 0.75) and Mx (r2 ranging from
0.40 to 0.78) expression (Table 6). In detail, the LoAg
with the highest viral copy numbers in the liver at 21
dpc had the highest levels of IFN-α (Figure 7b) and Mx







R2 P-value R2 P
7 dpc IFN-α 0.89 P < 0.0000 0.52 P
Mx 0.72 P < 0.0000 0.62 P
21 dpc IFN-α 0.66 P < 0.0000 0.42 P
Mx 0.69 P < 0.0000 0.41 Phigh viral loads, had lower levels of IFN-α and Mx. The
HiAg group, which had low viral copy numbers in the
liver by 21 dpc (Figure 6c), had insignificant expression
levels of both genes (Figure 7b and d). Put together, the
data in Figures 6 and 7 show that expression of IFN-α
and Mx correlated with increase in viral loads (Table 6).
Discussion
One of the greatest challenges in vaccine development is
to optimize antigen dose in order to generate a threshold
of antibody titer that can be used as a measure of pro-
tective immunity. Unlike studies done in humans where
challenge models are often not applicable for ethicalng the incubation and acute stages of infection
expression with viral loads in different genes
Liver Pancreas
-value R2 P-value R2 P-value
< 0.0006 0.27 P < 0.2670 0.54 P < 0.0733
< 0.0001 −0.18 P < 0.3059 0.59 P < 0.0002
< 0.0132 0.75 P < 0.0002 0.43 P < 0.0081
< 0.0160 0.78 P < 0.0000 0.40 P < 0.0163
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used in vaccine formulation corresponded with PCSP in
vaccinated fish after challenge with IPNV. This demon-
strates that it is possible to establish a threshold of anti-
gen dose required to protect fish from mortality that
would serve as a measure of vaccine efficacy. In
addition, antibody levels obtained after vaccination but
prior to challenge corresponded with PCSP, further aug-
menting the possibility of determining a threshold end
point of antibody titer that can serve as a signature of
protective immunity. This was in line with assertions
made by Pulendran et al. [34] that when a protective
threshold of antibody titer is achieved or exceeded, vac-
cination is assumed to have reached a signature of pro-
tective immunity. In higher vertebrates, these tests have
been standardized so that signatures of protective im-
munity based on thresholds of neutralizing antibodies
have been determined for different pathogens [35]. How-
ever, no similar threshold units of antibody titers have
been established in teleosts. In the present study, an
antigen dose of 2 × 1010 TCID50/mL yielding a mean
antibody titer ≥ 1.4 OD490 at challenge attained a PCSP ≥
90% after challenge with the highly virulent Norwegian
Sp strain NVI-015 in the HiAg group. Therefore these
findings demonstrate that at these threshold units of
antigen dose (2 × 1010 TCID50/mL) and antibody titer
(≥ 1.4 OD490) vaccination against IPNV infection
attained high protection (PCSP > 90%) in vaccinated fish.
However, it is interesting to note that reducing the
threshold unit of antigen dose by one log (101), lowered
the antibody titer by threefold and decreased protection
to less than half (PCSP ≤ 42%) as shown in the LoAg
group that was vaccinated with an antigen dose one log
lower than the HiAg group. Overall, these findings dem-
onstrate that in vaccinology, a suboptimal antigen dose
one log (101) lower than the protective threshold unit
can lead to significant differences in vaccine protection.
Progression of antibody responses for fish used in this
study can be divided into two stages namely the immune
induction and post challenge periods. Immune induction
covered the period between vaccination up to the time
of challenge at 8 wpv in which fish developed antibodies
in response to vaccination. At challenge (8 wpv), anti-
body levels in the HiAg were threefold higher than levels
in the LoAg suggesting that post vaccination antibody
responses were antigen dose dependent. The post
challenge period covered the incubation and acute stages
of infections. During the incubation period, antibody
levels in both the HiAg and LoAg groups declined,
which could be attributed to their utilization in virus
neutralization after challenge. Neutralization of virus by
antibodies could have played a major role in delaying
the onset of post challenge mortality in vaccinated fish
unlike the control group in which no antibodies werepresent to neutralize replicating virus; fish therefore
started dying by 19 dpc. It is likely that mortality in the
LoAg group was delayed until after depletion of anti-
bodies which gave way to an increase in virus replication
by 21 dpc. High antibody levels in the HiAg group could
have played a major role in suppressing the increase in
virus replication during the acute stage of infection
leading to delayed onset and reduction of mortality in
this group. While antibodies in the vaccinated groups
declined due to their usage in virus neutralization, con-
trol fish that had no antibodies prior to challenge devel-
oped antibody responses that increased to higher levels
during the acute stage of infection as an indication of a
primary response of exposure to the challenge virus.
This could explain reasons why the LoAg group had
lower antibody levels than the control group during
acute infection (21–56 dpc). The major difference
between the vaccinated and control fish is that anti-
bodies from vaccinated fish were generated in response
to vaccination from inactivated vaccines prior to chal-
lenge while antibodies from control fish were generated
in response to the challenge virus. Hence, antibodies
from control fish could not have played a major role in
post challenge protection because they were generated
after exposure to the challenge virus. On the contrary,
antibodies from vaccinated fish could have played a
major role in post challenge protection because they
were generated prior to challenge from inactivated vac-
cines for protection against the challenge virus.
One of the prime objectives in vaccination is to pre-
vent establishment of infection soon after exposure to
the virus. Overall infection rates of the current study
were higher in control fish during the incubation period,
followed by the LoAg group that had low antibody levels
with the lowest infection rates being in the HiAg that
had the highest antibody levels. This was consistent with
our earlier observations that fish vaccinated with less
potent vaccines get infected much earlier with higher
infection rates than fish vaccinated with more potent
vaccines [11]. Given that increase in antibody levels cor-
responded with decrease in overall infection rates, it is
likely that circulating antibody levels played an import-
ant role in preventing dissemination and seeding of virus
in the predilection sites in the HiAg group. This was
supported by virus re-isolation data in which the num-
ber of fish having viraemia was the lowest in the HiAg
group and was consistent with our previous study in
which we showed that high antibody levels were corre-
lated with the absence of viraemia, unlike the less pro-
tective vaccines that had early onset of viraemia and
linked to high infection rates [11]. Another important
observation made from this study was that although the
pancreas and liver are target organs prone to tissue da-
mage, the seeding of virus in the liver was delayed until
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in the pancreas occurred early during the incubation
period. Furthermore, these data show that for fish that
were only infected in the pancreas without involvement
of the liver, infection did not proceed to cause patho-
logical disease. These findings point to the importance
of involvement of the liver during acute infection. This
was clearly demonstrated in the HiAg group that had
low infection rates in the liver and yet the pancreas had
100% infection rates, but because the liver was not
infected in most fish, no pathological disease developed.
Consequently, the seeding of virus coupled with tissue
damage in the liver corresponded with an increase in
post challenge mortality in the LoAg and control groups
during acute infection. Conversely, the presence of high
antibody levels in the HiAg group corresponded with
low infection rates in the liver. Although we did not
determine the role of the cellular mediated immune re-
sponse in eliminating virus infected cells, these observa-
tions suggest that high antibody levels could play an
important role in preventing the seeding of virus in the
liver as a protective mechanism against tissue damage.
This was in line with observations made elsewhere that
preventing deposition of virus in target organs prevents
the establishment of clinical disease [36,37]. However, it
is important to point out that it is possible that other
arms of the immune system not evaluated in the present
study could have contributed to reducing post challenge
mortality. This was demonstrated in the LoAg group
that had lower antibody levels and higher viral copy
numbers at 21 dpc than the control group and yet this
group had less mortality than the control group.
As pointed out by Plotkin [35] the correlate of clinical
disease is not necessarily the same correlate that predicts
the cut-off against infection. In the present study, infec-
tion was detected in tissues with mean viral copy num-
bers ≤ 102.6 which corresponded with the expression of
innate immune genes. However, these viral copy num-
bers were inadequate to cause tissue damage in target
organs. It is only when viral copy numbers exceeded
107.0 that tissue damage was detected, implying that this
cutoff could serve as a correlate of pathology in target
organs. By determining the quantity of viral copy
numbers required to establish pathological disease,
immunization can be optimized to obtain antibody levels
able to prevent tissue damage. For example, in the case
of measles vaccines [38], antibody titers > 200 mIU/mL
were protective against infection, whereas titers between
120–200 mIU/mL were protective against clinical dis-
ease but not infection. Titers <120 mIU/mL were not
protective at all. Although we did not determine the cut-
off that prevents establishment of infection, our findings
show that at 1.4 OD490, antibody levels corresponded
with the absence of tissue damage in the HiAg group. Interms of tissue susceptibility, data presented here show
that limiting virus replication in the liver and pancreas
corresponded with failure to establish pathological dis-
ease during acute infection. This was shown in the HiAg
group that had low viral copy numbers linked to the ab-
sence of tissue damage. Conversely, copy numbers ≥
107.0 in the liver and pancreas of the LoAg and control
groups were linked to tissue damage and high mortality.
Although we did not rule out the possible involvement
of the cellular mediated immune response in eliminating
virus infected cells, these data suggest that antibodies
could play a pivotal role in suppressing virus replication
to levels below the correlate of pathology as a mode of
protection against tissue damage and mortality.
Innate immune genes like IFN and IFN-inducible
genes (IGS) are known to be the first line of defense
against viral infections [39-41]. Expression of IFN-α and
Mx correlated with establishment of infection in the
control group during the incubation period indicating
that upon infection, IPNV induces the expression of
early immune genes. Expression of these genes did not
only correlate with infection at predilection sites, but
was also highly correlated with an increase in viral copy
numbers suggesting that these genes could serve as bio-
markers of tissue tropism as well as indicators of in-
crease in virus replication. This entails that, instead of
tracking virus distribution and monitoring increase in
replication capacity, expression of these genes could
serve as alternative indicators of tissue tropism and an
increase in viral copy numbers. For example, high viral
loads in the liver during acute infection correlated with
high expression levels of both genes while low infection
rates during the incubation period were characterized by
low expression levels. In vaccinated fish, up-regulation
of these genes was indicative of low efficacy or vaccine
failure as shown in the LoAg group in which an increase
in viral copy number during acute infection was marked
with high levels of IFN-α and Mx. Conversely, down
regulation of these genes in the HiAg was indicative of
high protection linked to low viral copy numbers. Here,
we demonstrate for the time, that the kinetics of IFN-α
and Mx expression follow the distribution and replica-
tion of IPNV making these genes potential biomarkers
of infection progression as well as indicators of vaccine
efficacy.
In summary, this study has shown that the mechanism
of vaccine protection against IPNV infection is a
stepwise process in which vaccine induced protection
reduces post challenge infection rates as a first step. This
implies that some fish do not get infected and for fish
that get infected, the next mode of protection is to pre-
vent seeding of virus in target organs, particularly in the
liver. Finally, for fish that get infected in target organs,
protection is by reducing virus replication to levels
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relate of pathology based on viral copy numbers at
which tissue damage is established provides a bench-
mark against which vaccine protection can be measured.
Use of innate immune genes as indicators of tissue trop-
ism and increase in virus replication provide the first
methodological evidence that gene signatures can be
used as biomarkers of IPNV infection progression in
salmonids. We demonstrate that antigen dose in vaccine
formulation corresponds with vaccine efficacy and that
antibody levels can be used as a signature of protective
immunity against pathological disease and mortality.
Overall, these findings show that by streamlining testing
procedures, immunological thresholds that reliably
protect fish from disease can be established in IPNV
vaccinology.
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